Global Chinese Medicine Testing Market Growth (Status and Outlook) 2025-2031

The global Chinese Medicine Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Chinese medicine testing refers to the chemical, biological and pharmacological testing and analysis of Chinese medicinal materials, Chinese medicine preparations and other traditional Chinese medicine products to determine their quality, safety and effectiveness. The purpose of TCM testing is to ensure the quality and safety of TCM products, prevent the circulation of counterfeit and shoddy products, and protect the health rights and interests of consumers. Traditional Chinese medicine testing usually includes identification of Chinese herbal medicines, content determination, microbial testing, heavy metal and pesticide residue testing, etc. At the same time, the drug efficacy and clinical application value of traditional Chinese medicine preparations can also be evaluated by testing the dissolution rate, stability, and drug efficacy of traditional Chinese medicine preparations.

In order to ensure the quality and safety of traditional Chinese medicines, many international organizations and institutions have formulated standards and guidelines for the testing of traditional Chinese medicines, such as the European Pharmacopoeia, the United States Pharmacopoeia and the International Pharmacopoeia. These standards have played a role in promoting the development of the traditional Chinese medicine testing market.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Chinese Medicine Testing Industry Forecast” looks at past sales and reviews total world Chinese Medicine Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Chinese Medicine Testing sales for 2025 through 2031. With Chinese Medicine Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chinese Medicine Testing industry.

This Insight Report provides a comprehensive analysis of the global Chinese Medicine Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Chinese Medicine Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chinese Medicine Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chinese Medicine Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chinese Medicine Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Chinese Medicine Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Chinese Herbal Medicine
Chinese Patent Medicine

Segmentation by Application:
Laboratory
Factory

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Castco Testing Centre
Hong Kong Productivity Council (HKPC)
SGS
Lab Test One
CMA Testing
Agilent Technologies
Hong Kong Standards and Testing Centre
Nuherbs

Please note: The report will take approximately 2 business days to prepare and deliver.